Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes
Christopher R. Cogle(University of Florida), Fatih M. Uckun(University of Southern California), Leslie Pettiford(University of Florida), Elizabeth Wise(University of Florida), Zackary Beachamp(University of Florida), Bradley R. Collins(University of Florida), Raphael C. Bosse(University of Florida), Randall W. Brown, Kimberly E. Hawkins(University of Florida), Jan S. Moreb(University of Florida), Daniel Turner(University of Florida), John Hiemenz(Moffitt Cancer Center), Christina Cline(University of Florida), W. Stratford May(City of Cape Town), John R. Wingard(University of Florida Health), Jack W. Hsu(University of Florida Health), Maxim Norkin(Centre Hospitalier Universitaire Vaudois)
Cited by 15
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
|Clinical Infectious Diseases|2008|2.7k